LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in ...

When seizures stop the heart: The challenge of identifying and managing ictal asystole

People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...